JINDAL VINEET R. (Chief Financial Officer) received a stock award from ONKURE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/14/2021ACC: 0001209191-21-069448
Officer· Chief Financial Officer
Since Apr 2021
+130K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
130K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
454.5%
12/10/2021
6.60K→36.60K
Total
Net shares
+30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2021 | A · Award | +30K | — | — | 454.5% | 6.60K | 36.60K |
| Total | +30K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
100K shares
Shares
+100K
Strike price
6.69
Held after
100K
Exercisable
—
12/10/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock100K shares | 12/10/2021 | A · Award | +100K | 6.69 | — | 100K |